On August 10, 2005, the Federal Circuit affirmed the district court’s judgment that U.S. Patent No. 5,422,368, but not related U.S. Patent No. 5,296,504, which both related to a glaucoma drug marketed as Xalatan®, was

First Page		Document Content
Date: 2005-08-25 11:14:36 Law Property law Ethics Inequitable conduct United States law Prior art Term of patent Patent Claim Patent law United States patent law Civil law		On August 10, 2005, the Federal Circuit affirmed the district court’s judgment that U.S. Patent No. 5,422,368, but not related U.S. Patent No. 5,296,504, which both related to a glaucoma drug marketed as Xalatan®, was Document is deleted from original location. Use the Download Button below to download from the Web Archive. Download Document from Web Archive File Size: 178,60 KB

Document is deleted from original location. Use the Download Button below to download from the Web Archive.